Smith J. Jefferson
- SEC CIK
- 0001770169
In the past year, 2 open-market sale filings worth $60.0K and no purchases.
Current role at each company
- DTIL Precision Biosciences IncChief Research Officeras of Jun 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $60.0K
- 2 filings
- Net
- −$60.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Smith J. Jefferson as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 (view filing) | Feb 18 | 1 day | Smith J. JeffersonChief Research Officer | SSale | −4.92K | $3.84 | −$18.9K | −3.9%121.9K after | 10b5-1 |
| Jan 22, 2026 (view filing) | Jan 21 | 1 day | Smith J. JeffersonChief Research Officer | SSale | −10.2K | $4.03 | −$41.1K | −8.5%110.2K after | 10b5-1 |
| Mar 5, 2025 (view filing) | Mar 4 | 1 day | Smith J. JeffersonChief Research Officer | SSale | −154 | $4.91 | −$756.14 | −0.2%87.8K after | 10b5-1 |
| Jan 22, 2025 (view filing) | Jan 22 | Same day | Smith J. JeffersonChief Research Officer | SSale | −10.3K | $4.79 | −$49.3K | −10.5%87.4K after | 10b5-1 |
| Jun 11, 2024 (view filing) | Jun 10 | 1 day | Smith J. JeffersonChief Research Officer | SSale | −50 | $11.79 | −$589.5 | −0.1%68.6K after | |
| May 3, 2024 (view filing) | May 2 | 1 day | Smith J. JeffersonChief Research Officer | SSale | −154 | $10.32 | −$1.59K | −0.2%67.6K after | |
| Jan 23, 2024 (view filing)7:11 PM ET | Jan 23 | Same day | Smith J. JeffersonChief Research Officer | SSale | −28.0K | $0.37 | −$10.4K | −1.4%1.99M after |